JP2017531448A5 - - Google Patents

Download PDF

Info

Publication number
JP2017531448A5
JP2017531448A5 JP2017537016A JP2017537016A JP2017531448A5 JP 2017531448 A5 JP2017531448 A5 JP 2017531448A5 JP 2017537016 A JP2017537016 A JP 2017537016A JP 2017537016 A JP2017537016 A JP 2017537016A JP 2017531448 A5 JP2017531448 A5 JP 2017531448A5
Authority
JP
Japan
Prior art keywords
cell
cells
motif
ligand
fibronectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017537016A
Other languages
English (en)
Japanese (ja)
Other versions
JP6898240B2 (ja
JP2017531448A (ja
Filing date
Publication date
Priority claimed from FR1459539A external-priority patent/FR3026744B1/fr
Application filed filed Critical
Publication of JP2017531448A publication Critical patent/JP2017531448A/ja
Publication of JP2017531448A5 publication Critical patent/JP2017531448A5/ja
Application granted granted Critical
Publication of JP6898240B2 publication Critical patent/JP6898240B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017537016A 2014-10-06 2015-10-05 T細胞前駆細胞を生成するための方法 Active JP6898240B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1459539 2014-10-06
FR1459539A FR3026744B1 (fr) 2014-10-06 2014-10-06 Methode de generation de progeniteurs de cellules t
PCT/EP2015/072889 WO2016055396A1 (fr) 2014-10-06 2015-10-05 Méthode de génération de progéniteurs de cellules t

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020209370A Division JP2021072779A (ja) 2014-10-06 2020-12-17 T細胞前駆細胞を生成するための方法

Publications (3)

Publication Number Publication Date
JP2017531448A JP2017531448A (ja) 2017-10-26
JP2017531448A5 true JP2017531448A5 (https=) 2018-11-15
JP6898240B2 JP6898240B2 (ja) 2021-07-07

Family

ID=52102849

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017537016A Active JP6898240B2 (ja) 2014-10-06 2015-10-05 T細胞前駆細胞を生成するための方法
JP2020209370A Pending JP2021072779A (ja) 2014-10-06 2020-12-17 T細胞前駆細胞を生成するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020209370A Pending JP2021072779A (ja) 2014-10-06 2020-12-17 T細胞前駆細胞を生成するための方法

Country Status (11)

Country Link
US (1) US12071635B2 (https=)
EP (2) EP3204492B1 (https=)
JP (2) JP6898240B2 (https=)
CA (1) CA2963756C (https=)
DK (1) DK3204492T3 (https=)
ES (1) ES2914082T3 (https=)
FR (1) FR3026744B1 (https=)
HU (1) HUE059468T2 (https=)
PL (1) PL3204492T3 (https=)
PT (1) PT3204492T (https=)
WO (1) WO2016055396A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017173551A1 (en) 2016-04-08 2017-10-12 The Governing Council Of The University Of Toronto Method for generating progenitor t cells from stem and/or progenitor cells and use of same
ES2931530T3 (es) * 2017-02-13 2022-12-30 Hopitaux Paris Assist Publique Método para generar progenitores de células T
CA3091158A1 (en) 2018-02-14 2019-08-22 Sunnybrook Research Institute Method for generating cells of the t cell lineage
FR3079239A1 (fr) * 2018-03-23 2019-09-27 Centre National De La Recherche Scientifique Nouvelle methode d’obtention de cellules t a partir de cellules souches pluripotentes, et leurs utilisations
AU2019252878B2 (en) * 2018-04-10 2024-02-22 Stichting Sanquin Bloedvoorziening Chimeric Notch receptors
JP2023553313A (ja) 2020-11-30 2023-12-21 チョ ファーマ インコーポレイテッド 細胞を富化するための抗体
WO2023079082A1 (en) 2021-11-04 2023-05-11 Aphp (Assistance Publique - Hôpitaux De Paris) Method for generating nk cells
KR20250152088A (ko) 2023-02-22 2025-10-22 메이라지티엑스 셀 테라피스 흉선 재생 방법
KR20260041821A (ko) 2023-07-12 2026-03-27 메이라지티엑스 셀 테라피스 특이적 동형접합성 hla 일배체형을 갖는 세포 뱅크의 바이오뱅크 및 환자 치료를 위한 이의 용도
WO2025219552A1 (en) 2024-04-17 2025-10-23 Assitance Publique Hopitaux De Paris Method for producing t cell progenitors from human pluripotent stem cells
WO2025255678A1 (en) * 2024-06-14 2025-12-18 Stemcell Technologies Canada Inc. Compositions and methods for generating lymphoid lineage cells

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093531A (en) 1997-09-29 2000-07-25 Neurospheres Holdings Ltd. Generation of hematopoietic cells from multipotent neural stem cells
WO1999028486A1 (en) 1997-12-04 1999-06-10 Duke University Methods of isolating and using cd7+cd34-lin-hematopoietic cells
KR101331746B1 (ko) * 2003-08-22 2013-11-20 다카라 바이오 가부시키가이샤 세포 상해성 림프구의 제조 방법
WO2009097140A1 (en) 2008-01-30 2009-08-06 Memorial Sloan-Kettering Cancer Center Methods for off -the -shelf tumor immunotherapy using allogeneic t-cell precursors
EP2331679B1 (en) 2008-09-12 2017-04-19 Cryopraxis Criobiologia LTDA. Ischemic tissue cell therapy
AU2009311232B2 (en) 2008-11-07 2014-10-30 Sunnybrook Health Sciences Centre Human progenitor T-cells
US8871510B2 (en) * 2009-12-03 2014-10-28 University Of Utah Research Foundation Methods for generating T lymphocytes from hematopoietic stem cells
CA2795627C (en) 2010-04-09 2023-03-14 Fred Hutchinson Cancer Research Center Compositions and methods for providing hematopoietic function without hla matching
US10391126B2 (en) 2011-11-18 2019-08-27 Board Of Regents, The University Of Texas System CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
EP2788476B1 (en) 2011-12-08 2019-05-22 Fred Hutchinson Cancer Research Center Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
WO2014110353A1 (en) * 2013-01-11 2014-07-17 The Trustees Of The University Of Pennsylvania Notch ligand bound bicompatible substrates and their use in bone formation
EP3027755B1 (en) 2013-08-02 2019-10-09 The Regents of The University of California Engineering antiviral t cell immunity through stem cells and chimeric antigen receptors
US20170128556A1 (en) 2013-12-26 2017-05-11 Thyas Co. Ltd. Immunotherapy using t precursor cells derived from pluripotent stem cells having rearranged t cell receptor genes
CA2945388A1 (en) 2014-04-23 2015-10-29 Board Of Regents, The University Of Texas System Chimeric antigen receptors (car) for use in therapy and methods for making the same
CN106062185A (zh) 2014-04-24 2016-10-26 美天旎生物技术有限公司 用于自动生成遗传修饰的t细胞的方法
WO2016039933A1 (en) * 2014-09-11 2016-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Lentiviral vector for treating hemoglobin disorders

Similar Documents

Publication Publication Date Title
JP2017531448A5 (https=)
CN107922925B (zh) 用于自然杀伤细胞扩增的方法
JP6898240B2 (ja) T細胞前駆細胞を生成するための方法
ES2931530T3 (es) Método para generar progenitores de células T
CA2954534C (en) Manufacture and cryopreservation of fucosylated cells for therapeutic use
JP6775426B2 (ja) 臍帯血由来のプールnk細胞並びにがん及び慢性感染症の治療のためのこれらの用途
Brauer et al. T cell genesis: in vitro veritas est?
Alidadi et al. Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects
IL277467B2 (en) Method for producing natural killer cells
Netsrithong et al. Advances in adoptive cell therapy using induced pluripotent stem cell-derived T cells
JP2023522326A (ja) 条件付き不死化に関する制御可能な導入遺伝子を含む人工多能性細胞
US20200263136A1 (en) Methods of preparing hematopoietic progenitor cells in vitro
CN114621920A (zh) 一种由造血干祖细胞向nk细胞分化的方法及培养基
JP7743980B2 (ja) ヒトT細胞由来iPS細胞由来の細胞傷害性T細胞
Zhu et al. Feeder-free advances in T cell development and therapy
Mehra et al. The emerging role of induced pluripotent stem cells as adoptive cellular immunotherapeutics
Jiang et al. Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
JP2025533901A (ja) グローバル、民族、又は疾患特異的集団をカバーするための同種異系細胞療法のための免疫適合性細胞
Ren et al. Umbilical cord blood hematopoietic stem cell expansion ex vivo
Lisini et al. Stem cell production: Processes, practices, and regulation: Stem cell culture and expansion: Role of culture, types of cells, growth conditions, media nutrients, growth factors, growth phase cycle
WO2008056734A1 (en) Method for producing dendritic cells from human embryonic stem cells
Chen et al. Advances and Challenges in the Ex Vivo Production of Megakaryocytes and Platelets
Stockland et al. BRIDGING RESEARCH AND CLINICAL PRACTICE OF ADVANCE OFF-THE-SHELF ALLOGENEIC NATURAL KILLER CELL THERAPY
Cantore et al. 286. Genome Editing of Inducible Cell Lines for Scalable Production of Improved Lentiviral Vectors for Human Gene Therapy
Jain et al. Stem Cells: Allogeneic Cells for Cellular Immunotherapy